LLY
Eli Lilly and Company
1,142.90$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 39.7% | 40.2% | 39.4% | 42.0% | 41.6% | 41.6% | 46.2% | 49.4% | 54.0% | 49.5% | 47.0% | 45.5% | |
| 4.1% | 4.4% | 3.8% | 4.5% | 4.5% | 4.2% | 3.5% | 3.3% | 8.5% | 6.4% | 4.4% | 6.2% | |
| 4.3% | 4.6% | 4.0% | 4.7% | 4.7% | 4.3% | 3.6% | 3.5% | 8.6% | 6.5% | 4.5% | 6.3% | |
| 17.9% | 17.7% | 15.7% | 18.2% | 15.9% | 16.9% | 15.7% | 17.0% | 16.9% | 17.9% | 18.2% | 16.5% | |
| 8.5% | 9.0% | 9.5% | 9.0% | 9.9% | 9.6% | 10.4% | 10.9% | 10.6% | 12.2% | 12.5% | 11.8% | |
| 20.5% | – | – | – | 21.4% | 21.7% | 20.7% | 20.3% | 19.4% | 21.9% | – | – | |
| 7.1% | 7.7% | 7.7% | 8.0% | 7.6% | 7.3% | 6.5% | 5.7% | 5.1% | 5.2% | 5.3% | 6.2% | |
| 11.7% | 10.8% | 10.6% | 9.2% | 8.6% | 7.8% | 6.7% | 5.9% | 5.6% | 5.8% | 6.3% | 12.7% | |
| 80.5% | 83.0% | 79.8% | 81.0% | 81.1% | 81.9% | 82.3% | 81.8% | 79.2% | 76.4% | 73.2% | 76.2% | |
| 38.0% | 42.6% | 29.1% | 37.7% | 32.6% | 36.0% | 33.6% | 38.7% | 34.9% | 31.3% | 31.4% | 33.6% | |
| 3.9% | 10.8% | 2.6% | 7.2% | 2.7% | 6.5% | 4.5% | 5.7% | 1.4% | 1.5% | 3.4% | 5.0% | |
| 4.2% | 4.1% | 3.9% | 4.1% | 3.8% | 4.1% | 3.9% | 4.0% | 3.7% | 4.8% | 4.3% | 4.3% | |
| 30.9% | 28.6% | 38.4% | 33.0% | 38.4% | 36.2% | 38.6% | 33.9% | 35.6% | 36.3% | 33.8% | 33.6% | |
| 19.4% | 16.8% | 20.0% | 18.9% | 18.8% | 18.0% | 17.6% | 18.1% | 20.7% | 23.6% | 26.8% | 23.8% | |
| 17.8% | 16.1% | 19.6% | 18.3% | 18.0% | 17.2% | 16.9% | 17.2% | 19.4% | 21.8% | 25.3% | 22.4% | |
| 1.6% | 1.4% | 1.4% | 1.3% | 1.2% | 1.1% | 1.0% | 0.9% | 0.8% | 0.8% | 0.8% | 0.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.